TINOS THERAPEUTICS Trademark
Trademark Overview
On Thursday, January 29, 2026, a trademark application was filed for TINOS THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the TINOS THERAPEUTICS trademark a serial number of 99622513. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, April 23, 2026. This trademark is owned by Tinos Therapeutics, Inc.. The TINOS THERAPEUTICS trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Custom manufacturing of pharmaceuticals
Pharmaceutical products development; Pharmaceutical research and development
Genetic analysis for medical purposes
pharmaceuticals for the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), cancer, and obesity; pharmaceuticals for the treatment of life-threatening diseases; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics for use in the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), cancer, and obesity; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics that feature RNA as their active ingredient; pharmaceuticals, namely, small molecule therapeutics that induce changes in the chemical modifications of ribonucleic acid (RNA); pharmaceuticals, namely, viral vector therapeutics that induce changes in the chemical modifications of ribonucleic acid (RNA)
General Information
| Serial Number | 99622513 |
| Word Mark | TINOS THERAPEUTICS |
| Filing Date | Thursday, January 29, 2026 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Thursday, April 23, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Custom manufacturing of pharmaceuticals |
| Goods and Services | Pharmaceutical products development; Pharmaceutical research and development |
| Goods and Services | Genetic analysis for medical purposes |
| Goods and Services | pharmaceuticals for the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), cancer, and obesity; pharmaceuticals for the treatment of life-threatening diseases; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics for use in the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), cancer, and obesity; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics that feature RNA as their active ingredient; pharmaceuticals, namely, small molecule therapeutics that induce changes in the chemical modifications of ribonucleic acid (RNA); pharmaceuticals, namely, viral vector therapeutics that induce changes in the chemical modifications of ribonucleic acid (RNA) |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 29, 2026 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 29, 2026 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 29, 2026 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 29, 2026 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Tinos Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Barrington, RI 02806
US |
Trademark Events
| Event Date | Event Description |
| Thursday, January 29, 2026 | NEW APPLICATION ENTERED |
| Thursday, January 29, 2026 | APPLICATION FILING RECEIPT MAILED |
| Saturday, January 31, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, April 21, 2026 | ASSIGNED TO EXAMINER |
| Thursday, April 23, 2026 | NON-FINAL ACTION WRITTEN |
| Thursday, April 23, 2026 | NON-FINAL ACTION E-MAILED |
| Thursday, April 23, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
